VIRGINIA HOEFGEN: Open Payments
NPI 1114372083 · AUGUSTA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,483 in 67 payments from 13 companies in 2025. Trend: 2023 $917 · 2024 $796 · 2025 $1,483
Food & beverage: $1,483
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $459 |
| ABBVIE INC. | 11 | $276 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $197 |
| Novo Nordisk Inc | 16 | $170 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $141 |
| Vanda Pharmaceuticals Inc. | 2 | $55 |
| PFIZER INC. | 3 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Lilly USA, LLC | 1 | $21 |
Products named: AIRSUPRA, QULIPTA, Kerendia, BREZTRI, CAPLYTA, Wegovy, REXULTI, FANAPT.
Industry payments across KS — which companies pay providers there.
